Acute Myeloid Leukemia Clinical Trials in Beijing, Beijing Municipality
16 recruitingBeijing, Beijing Municipality, China
Showing 1–16 of 16 trials
Recruiting
Phase 1Phase 2
A Study of BGB-11417 in Participants With Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasm
BeiGene260 enrolled46 locationsNCT04771130
Recruiting
Phase 1Phase 2
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Breast CancerLiver CancerNon-small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech85 enrolled1 locationNCT07410494
Recruiting
Phase 2
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Newly Diagnosed Acute Myeloid Leukemia (AML)Intensive Chemotherapy UnfitAge ≥60
First Affiliated Hospital of Zhejiang University25 enrolled5 locationsNCT07172204
Recruiting
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Peking University People's Hospital283 enrolled2 locationsNCT06452732
Recruiting
Phase 1
A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Sichuan Baili Pharmaceutical Co., Ltd.130 enrolled8 locationsNCT05924750
Recruiting
Phase 1
A Study of GLB-001 in Patients With Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelofibrosis+3 more
Hangzhou GluBio Pharmaceutical Co., Ltd.108 enrolled14 locationsNCT06378437
Recruiting
Phase 3
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Acute Myeloid Leukemia
Hutchmed316 enrolled53 locationsNCT06387069
Recruiting
Phase 2
Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)Relapsed/Refractory Acute Myeloid Leukemia (AML)High Risk Acute Myeloid Leukemia(AML)
Peking University People's Hospital56 enrolled1 locationNCT06869265
Recruiting
Phase 2
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
Acute Myeloid LeukemiaFirst Line Therapy
Chinese PLA General Hospital160 enrolled1 locationNCT06928376
Recruiting
Early Phase 1
Off-the-shelf CD123 CAR-NK for R/R AML
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, Refractory
Peking University People's Hospital12 enrolled1 locationNCT06201247
Recruiting
Phase 3
Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia
Acute Myeloid Leukemia
Peking University People's Hospital96 enrolled1 locationNCT06802718
Recruiting
Phase 1Phase 2
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
Acute Myeloid LeukemiaAMLAML, Adult+1 more
Essen Biotech85 enrolled1 locationNCT06420063
Recruiting
Phase 1
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Ascentage Pharma Group Inc.102 enrolled14 locationsNCT04275518
Recruiting
Phase 1
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.100 enrolled7 locationsNCT06550713
Recruiting
Phase 2
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
Minimal Residual DiseaseMyelodysplastic SyndromesRefractory Acute Myeloid Leukemia+1 more
Beijing 302 Hospital67 enrolled1 locationNCT06536959
Recruiting
Not Applicable
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
Acute Myeloid Leukemia
Affiliated Hospital to Academy of Military Medical Sciences20 enrolled1 locationNCT05000801